End-stage liver disease in persons with hemophilia and transfusion-associated infections.
James J. Goedert(National Cancer Institute), Angelos Hatzakis(National and Kapodistrian University of Athens), Donna DiMichele, Anne Angiolillo(Children's National), Craig M. Kessler(Georgetown University), Louis M. Aledort(Mount Sinai Hospital), Kenneth E. Sherman(Harvard University), T Mandalaki(National Institutes of Health), Barbara L. Kroner(RTI International), Margaret W. Hilgartner(New York Academy of Medicine), Michael M. Lederman(Center for Environmental Health), Marilyn J. Manco‐Johnson(Rocky Mountain Diabetes and Osteoporosis Center), Cindy Leissinger(National Institutes of Health), Philip S. Rosenberg(National Cancer Institute), Philippe de Moerloose(Hôpital Beau-Séjour), Alan R. Cohen(Children's Hospital of Philadelphia), Gilbert White(Thiel College), Liliana Preiss(RTI International), Naomi L.C. Luban(National Institutes of Health), M. Elaine Eyster(National Cancer Institute)
PubMed
September 1, 2002
Cited by 165
Related Papers
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS
|Science|1984|3.6k
Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the <i>CKR5</i> Structural Gene
|Science|1996|2.5k
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
|Science|2004|1.2k
Standards for epidemiologic studies and surveillance of epilepsy
|Epilepsia|2011|1k